Skip to main content
Ammar Al-Chalabi

Professor Ammar Al-Chalabi MB, ChB, PhD

Professor of Neurology and Complex Disease Genetics

Research interests

  • Neuroscience

Biography

My research focuses on amyotrophic lateral sclerosis, also known as ALS or motor neuron disease. My research team works on finding the causes of ALS, and what might influence the way the disease manifests and progresses, particularly where this involves genes, environmental exposures, or changes in thinking and coping. I lead the Motor Neuron Disease reseach theme at the NIHR Maudsley Biomedical Research Centre.

I have also held fellowships and exchange positions abroad at Massachusetts General Hospital, Harvard University and Cold Spring Harbor Laboratory. I set up the MSc in Clinical Neuroscience at King's College London, which is our clinical research trainee programme.

I have authored more than 250 peer-reviewed papers and hold extensive external grant funding, including three current and six recently completed programme grants, as well as funding from Medical Research Council, Horizon 2020, and National Institute for Health and Care Research.

Please see my Research Staff Profile for more detail

Key collaborators

  • Professor Leonard van den Berg, University Medical Center Utrecht
  • Professor Orla Hardiman, Trinity College Dublin
  • Professor Christopher McDermott, University of Sheffield
  • Professor Chris Shaw, King's College London

Research

RHAPSODY Study
The RHAPSODY Study

Clinical Feasibility of Speech Phenotyping for Remote Assessment of Neurodegenerative and Psychiatric disorders (RHAPSODY)

Project status: Ongoing

News

Professor Ammar Al-Chalabi elected as Fellow of the Academy of Medical Sciences

Professor Ammar Al-Chalabi has been elected as a Fellow of the prestigious Academy for his remarkable contributions to advancing biomedical and health...

Prof-Ammar-Al-Chalabi

King's College London and LifeArc team up to accelerate MND treatment development

LifeArc has pledged £1.5 million to fund a new two-year collaborative partnership with King’s College London.

Molecules MND

Three King's academics elected as Fellows of the Academy of Medical Sciences

Professors Ammar Al-Chalabi, Maddy Parsons and Jane Sandall have been elected as Fellows of the prestigious Academy in recognition of their industry-leading...

Academic Fellows

New research institute to accelerate the search for a cure for MND

A new research institute to accelerate the search for a cure for motor neuron disease (MND, also known as ALS), launches today in London.

Motor neuron

New programme to move potential MND drugs into clinical trials faster

A ground-breaking experimental medicine programme that will enable researchers to more rapidly screen potential drugs in people with motor neuron disease...

Research Lab

PrecisionLife completes data access agreement with King's College London to enable new precision neuroscience treatments and diagnostics in MND/ALS

The techbio company, PrecisionLife, announced that it has agreed a data access and licensing agreement with King’s College London to enable it to generate and...

A person at a laptop keyboard typing, you can only see their hands and the keyboard. A padlock logo is in the middle to show data protection.

Secretary of State for Health and Social Care visits King's College London

Following a meeting of sector leaders, the Rt Hon Stephen Barclay MP, Secretary of State for Health and Social Care, met with scientists from King’s College...

Steve Barclay Ammar Al-Chalabi

Treatment for Motor Neurone Disease shows promise

A trial investigating a new treatment for amyotrophic lateral sclerosis (ALS) has shared promising results.

molecules

New £4.25 million grant kick starts UK-wide collaborative research effort to end motor neuron disease

A group of charities and government research organisations has awarded £4.25 million to MND experts at six UK universities to kick start collaborative efforts...

Research Lab

Professor Ammar Al-Chalabi Appointed as Co-Chair of NINDS ALS Strategic Plan Working Group

The U.S. National Institute of Neurological Disorders and Stroke (NINDS) has formed a strategic planning process to identify the highest priorities for...

Ammar Al Chalabi 780x440

Research

RHAPSODY Study
The RHAPSODY Study

Clinical Feasibility of Speech Phenotyping for Remote Assessment of Neurodegenerative and Psychiatric disorders (RHAPSODY)

Project status: Ongoing

News

Professor Ammar Al-Chalabi elected as Fellow of the Academy of Medical Sciences

Professor Ammar Al-Chalabi has been elected as a Fellow of the prestigious Academy for his remarkable contributions to advancing biomedical and health...

Prof-Ammar-Al-Chalabi

King's College London and LifeArc team up to accelerate MND treatment development

LifeArc has pledged £1.5 million to fund a new two-year collaborative partnership with King’s College London.

Molecules MND

Three King's academics elected as Fellows of the Academy of Medical Sciences

Professors Ammar Al-Chalabi, Maddy Parsons and Jane Sandall have been elected as Fellows of the prestigious Academy in recognition of their industry-leading...

Academic Fellows

New research institute to accelerate the search for a cure for MND

A new research institute to accelerate the search for a cure for motor neuron disease (MND, also known as ALS), launches today in London.

Motor neuron

New programme to move potential MND drugs into clinical trials faster

A ground-breaking experimental medicine programme that will enable researchers to more rapidly screen potential drugs in people with motor neuron disease...

Research Lab

PrecisionLife completes data access agreement with King's College London to enable new precision neuroscience treatments and diagnostics in MND/ALS

The techbio company, PrecisionLife, announced that it has agreed a data access and licensing agreement with King’s College London to enable it to generate and...

A person at a laptop keyboard typing, you can only see their hands and the keyboard. A padlock logo is in the middle to show data protection.

Secretary of State for Health and Social Care visits King's College London

Following a meeting of sector leaders, the Rt Hon Stephen Barclay MP, Secretary of State for Health and Social Care, met with scientists from King’s College...

Steve Barclay Ammar Al-Chalabi

Treatment for Motor Neurone Disease shows promise

A trial investigating a new treatment for amyotrophic lateral sclerosis (ALS) has shared promising results.

molecules

New £4.25 million grant kick starts UK-wide collaborative research effort to end motor neuron disease

A group of charities and government research organisations has awarded £4.25 million to MND experts at six UK universities to kick start collaborative efforts...

Research Lab

Professor Ammar Al-Chalabi Appointed as Co-Chair of NINDS ALS Strategic Plan Working Group

The U.S. National Institute of Neurological Disorders and Stroke (NINDS) has formed a strategic planning process to identify the highest priorities for...

Ammar Al Chalabi 780x440